Viscient Biosciences: Funding, Investors & Team (Oct 2026)
Viscient Biosciences is a biotechnology company working at the intersection of human 3D tissue technology and multi-omics (genomics, transcriptomics, metabolomics) analysis to develop drugs across a range of therapeutic areas, with an initial focus in non-alcoholic steatohepatitis (NASH,“fatty liver disease”). Founded and staffed by a team composed of former Organovo and Ardea Biosciences scientists and entrepreneurs, Viscient is driving a revolution in drug discovery, overthrowing the old paradigm of discovery in animal models.
Viscient Biosciences has raised $1.0M across 1 funding round on record, the most recent a Debt Financing of $1.0M announced in Sep 2021.
That round is below the $8.4M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Viscient Biosciences Company Profile and Key Stats
Latest funding round on record: Sep 2021.
Viscient Biosciences Funding Rounds
Viscient Biosciences Founders and Leadership Team
No contact details are on record for this team yet.
Viscient Biosciences Funding Compared to Other Biotechnology Startups
Viscient Biosciences' latest round of $1.0M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Viscient Biosciences in Biotechnology and San Diego
Companies Similar to Viscient Biosciences
Prolific Machines is a biotech company located in San Francisco, California, that was established in 2020. It…
Altay Therapeutics is a biotech company focused on finding and discovering small molecule therapies for…
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
Viscient Biosciences Funding FAQs
What does Viscient Biosciences do?
Viscient Biosciences is a biotechnology company working at the intersection of human 3D tissue technology and multi-omics (genomics, transcriptomics, metabolomics) analysis to develop drugs across a range of therapeutic areas, with an initial focus in non-alcoholic steatohepatitis (NASH,“fatty liver disease”). Founded and staffed by a team composed of former Organovo and Ardea Biosciences scientists and entrepreneurs, Viscient is driving a revolution in drug discovery, overthrowing the old paradigm of discovery in animal models.
How much funding has Viscient Biosciences raised?
Viscient Biosciences has raised $1.0M across 1 round on record. The most recent is a Debt Financing of $1.0M announced in Sep 2021.
When did Viscient Biosciences last raise funding?
Viscient Biosciences' most recent funding round on record is a Debt Financing of $1.0M, announced in Sep 2021.
Who is the CEO of Viscient Biosciences?
Keith Murphy is listed as CEO at Viscient Biosciences.
Where is Viscient Biosciences headquartered?
Viscient Biosciences is based in San Diego, California, United States.
How many employees does Viscient Biosciences have?
Viscient Biosciences is in the 1-10 employee band.
How does Viscient Biosciences' funding compare to other Biotechnology startups?
Viscient Biosciences' latest round of $1.0M is below the $8.4M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's Viscient Biosciences Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Viscient Biosciences is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.